In a groundbreaking study, semaglutide (2.4 mg) has shown remarkable benefits for patients with heart failure and obesity. Compared to a placebo, semaglutide led to significant reductions in symptoms, improved exercise function, and substantial weight loss. This could revolutionize heart failure management. Dive into the study below for more details. ?? https://lnkd.in/dnr3ytYY
iThriveMD
医疗机构
San Diego，California 176 位关注者
We bring together innovative therapies to optimize health & wellness.
关于我们
At iThriveMD, our aim is to unlock your full potential and enhance your health span. Utilizing state-of-the-art screening methods, we focus on key markers of aging, providing proven and safe solutions like IV nutrition, peptides, hormone replacement, and more.
- 网站
-
www.ithrivemd.com
iThriveMD的外部链接
- 所属行业
- 医疗机构
- 规模
- 11-50 人
- 总部
- San Diego，California
- 类型
- 私人持股
- 创立
- 2022
- 领域
- Anti-Aging Treatments、Hormone Replacement Therapy、Men's Health Services、Women's Health Services、Weight Management、Nutritional Counseling、Regenerative Medicine、IV Nutrition Therapy、Aesthetic Medicine、Sexual Health、Stress Management、Pain Management、Immune Support、Telehealth Services、Wellness Coaching、Genetic Testing、Bio-identical Hormones、Vitamin and Mineral Infusions、Chronic Disease Management、Telehealth Services和Regenerative Medicine